FDA Investigator Cheron M Portee
Cheron M Portee has conducted inspections on 45 sites in 1 countries as of 06 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
45
Last Inspection Date:
06 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Cheron M Portee:
Alan M Stevens,
Alexandra B Pitkin,
Allen F Hall,
Amalia C Himaya,
Angela Shepas,
Anita Narula, PhD,
Barry Cherney, PhD,
Bichsa T Tran,
Bo Chi, PhD,
Brien C Fox,
Carla J Lundi,
Caryn M Mcnab,
Christina C Santos,
Christina V Santos,
Colleen E Burke,
Comyar Shoghi,
Corrine M Carter,
Courtney N Long,
Daniel W Cline,
Davinna Ligons, PhD,
Deborah A Greco,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Dolores Harper,
Donna Ltartaglino Besone,
Durell L Giles,
Elizabeth A Dakan,
Eric S Pittman,
Esther C Broner, PhD,
Farwa Z Razvi,
Frances Namuswe, PhD,
Gene D Arcy,
Grace P Santos,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Ian A Pilcher,
Iris C Macinnes,
Ivar J Sohn,
James R Fleckenstein,
Jamie M Du,
Janet Pulver,
Jasmine Y Wang,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Joanne M Schlossin,
Jocelyn E Massey,
Joel Welch, PhD,
John R Myung,
Julian C Hanson,
Junho Pak,
Ka L Wong,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kham Phommachanh,
Kim Lthomas Cruse,
Kirsten S Tharp,
Korina Serrano,
Lakecha N Lewis,
Laura Fontan, MS,
Leigh Anne Myers,
Leonard H Lavi,
Linda Galindo,
Marcia B Williams,
Marcus F Yambot,
Matthew M Vernon,
Maxyne T Lam,
Michael D Garcia,
Michelle A Marsh,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Myra K Casey,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Omotunde O Osunsanmi,
Peter S Diak,
Rebecca Rodriguez,
Richmond K Yip,
Robert D Tollefsen,
Robert Darius,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Ronda Rloyd Jones,
Sarah A Hassas,
Sarah Arden,
Scott R Nichols, PhD,
Sharon L Matson,
Sidney B Priesmeyer,
Sonia R Peterson,
Stanley Au,
Stephen R Souza,
Steven Fong, MS, PhD,
Taichun Qin, PhD,
Tamika White,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thomas R Beilke,
Uttaniti Limchumroon (Tom),
Valerie L Whipp,
Veronica L Bush,
Wr Bowman,
Yumi J Hiramine,
Yvonne C Wilkes
Cheron M Portee's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2023 | FDA 483 | Dwayne Logan, M.D. - Form 483, 2023-08-01 |
September, 2021 | FDA 483 | Sarah E. Zauber, M.D. - Form 483, 2021-09-16 |
February, 2023 | FDA 483 | Merrill K. Shum, M.D. - Form 483, 2023-02-15 |
September, 2021 | EIR | Sarah E. Zauber, M.D. - EIR, 2021-09-16 |
May, 2022 | FDA 483 | Richard H. Hass, M.D. - Form 483, 2022-05-13 |
August, 2022 | FDA 483 | Sunil Rangappa M.D. - Form 483, 2022-08-01 |
July, 2021 | FDA 483 | Abid H. Khan MD - Form 483, 2021-07-02 |
February, 2024 | FDA 483 | Nana Barseghian, M.D. - Form 483, 2024-02-16 |
January, 2024 | FDA 483 | Krishnansu S. Tewari, M.D. - Form 483, 2024-01-23 |
October, 2023 | FDA 483 | Lisa S. Wang, M.D. - Form 483, 2023-10-13 |
October, 2021 | EIR | Michael S Panutich, MD - EIR, 2021-12-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more